3 Stocks Pulling The Health Services Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 11 points (0.1%) at 16,218 as of Tuesday, Feb. 25, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,600 issues advancing vs. 1,298 declining with 186 unchanged.

The Health Services industry currently sits down 0.4% versus the S&P 500, which is up 0.2%. On the negative front, top decliners within the industry include Tenet Healthcare ( THC), down 8.0%, Fresenius Medical Care AG & Co. KGaA ( FMS), down 5.4%, Community Health Systems ( CYH), down 3.9%, ResMed ( RMD), down 2.9% and DaVita HealthCare Partners ( DVA), down 1.5%. A company within the industry that increased today was Agilent Technologies ( A), up 1.2%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. WellPoint ( WLP) is one of the companies pushing the Health Services industry lower today. As of noon trading, WellPoint is down $0.77 (-0.8%) to $90.16 on light volume. Thus far, 865,495 shares of WellPoint exchanged hands as compared to its average daily volume of 2.4 million shares. The stock has ranged in price between $89.98-$91.66 after having opened the day at $91.66 as compared to the previous trading day's close of $90.93.

WellPoint, Inc., a health benefits company, through its subsidiaries, provides a range of medical and specialty products in the United States. WellPoint has a market cap of $26.2 billion and is part of the health care sector. Shares are down 1.6% year-to-date as of the close of trading on Monday. Currently there are 6 analysts that rate WellPoint a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates WellPoint as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full WellPoint Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Baxter International ( BAX) is down $0.48 (-0.7%) to $69.00 on light volume. Thus far, 622,047 shares of Baxter International exchanged hands as compared to its average daily volume of 3.2 million shares. The stock has ranged in price between $68.81-$69.47 after having opened the day at $69.47 as compared to the previous trading day's close of $69.48.

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $37.6 billion and is part of the health care sector. Shares are down 0.1% year-to-date as of the close of trading on Monday. Currently there are 4 analysts that rate Baxter International a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Baxter International Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, UnitedHealth Group ( UNH) is down $0.63 (-0.8%) to $75.38 on light volume. Thus far, 1.3 million shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 4.7 million shares. The stock has ranged in price between $75.14-$76.14 after having opened the day at $75.98 as compared to the previous trading day's close of $76.01.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $73.0 billion and is part of the health care sector. Shares are up 0.9% year-to-date as of the close of trading on Monday. Currently there are 14 analysts that rate UnitedHealth Group a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates UnitedHealth Group as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and attractive valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full UnitedHealth Group Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

How Walmart and Costco Could See a Future Flush With Profits Thanks to an Abundance of Cute Puppies

How Walmart and Costco Could See a Future Flush With Profits Thanks to an Abundance of Cute Puppies

U.S. Stocks Open Higher as Anthem Buys Cigna in $54 Billion Deal

U.S. Stocks Open Higher as Anthem Buys Cigna in $54 Billion Deal

Anthem Buying Cigna in $54.2 Billion Cash and Stock Deal

Anthem Buying Cigna in $54.2 Billion Cash and Stock Deal

Cigna Shares Soar on Reports of $48 Billion Anthem Buyout

Cigna Shares Soar on Reports of $48 Billion Anthem Buyout

Anthem’s Massive Data Breach Could Affect Customers for Years

Anthem’s Massive Data Breach Could Affect Customers for Years